Bioinformatics products. Bioinformatics services. R&D.
We deliver an intuitive cloud-based platform for NGS data analysis and clinical interpretation.
Built by engineers, trusted by industry specialists
Powering genomic medicine via automated NGS data reporting
Scaling interpretation
Perform thousands of analyzes simultaneously by automating the process.
Safety and quality
The platform complies with industry reg.: ISO13485, HIPAA, GDPR, IEEE 2791-2020 (BCO).
Ease of use
The platform does not require qualified personnel to operate.
Tailoring analysis
Ready-to-use customized workflows for diagnosis, therapy, and prevention on one platform.
Sample collection
Sequencing DNA
Raw NGS data LIMS
:
Integration
Secondary & tertiary analysis
GeneSpect™ Reporter
Clinical decision
End-to-end fully automatic pipelines for raw genetic data analysis.
GeneSpect Hereditary Reporter
GeneSpect Somatic Reporter
GeneSpect PGx Reporter
GeneSpect PRS Reporter
Database of >6000 polygenic scores derived from available GWAS results
Learn more
Full control of how the data gets analyzed and reported is now in hands of the user.
Customica builder
Learn more
01
Create an account
Create an account and easily upload your sample with raw NGS data.
02
Choose a workflow
Choose the workflow, manage input and run analysis.
03
Check the results
Check the analysis progress on your dashboard and results when completed. Make decisions based on the clinical insight report.
Certificaton and compliance, RD, validation
Completed R&D projects
Validation
What others say about us
“The iFlow platform has a very intuitive interface and allows for a quick and precise analysis of NGS samples. It does not require bioinformatics skills from its users and it accelerates the process of diagnosis in a cost- and time-efficient way. The user pays only per analysis, there are no upfront costs nor installation required or cost of high-power computer facilities. The program runs on its own servers. The reports generated via iFlow platform covered the information about variant pathogenicity necessary for the diagnosis of hereditary disorders among our patients.”
Center for Medical Genetics GENESIS
“We have been using the iFlow platform from the very beginning - we’ve also participated in the beta-tests. The app “facilitated the diagnosis of genetic diseases related to the neuromuscular system. We are convinced that the application fulfills its role 100%, enabling very fast and accurate analyses of exome and genome samples, in various areas of interest.
Mossakowski Medical Research Centre, Polish Academy Of Sciences
Intelliseq has completed a number of orders for OpenExome (currently AnalitykGenetyka) regarding sequencing and bioinformatic analysis of genetic data. We confirm that the services were performed properly and on time. We recommend Intelliseq as a reliable contractor.
Analityk GenetykaAnalityk Genetyka
Intelliseq performed for us the sequencing of the full transcriptome of RNA samples and bioinformatics analysis of the obtained data. I confirm that the service was performed properly and on time. I recommend Intelliseq as a reliable contractor.
Jagiellonian University Medical College
We’ve tested the iFlow platform and are impressed with its functionality and simplicity of use. It enables users to transfer raw DNA data into full reports with clinical insights with no bioinformatics skills needed. We recommend using the iFlow platform especially for entities that want to quickly access genome-based diagnostics market and precision medicine with full cost control.
ixLayer
We use the iFlow platform for the RNA-seq analyses within our research projects in the Department of Molecular Neuropharmacology. The analyses were carried out quickly and accurately without any problems. iFlow met all our expectations and we are happy to recommend it.
Maj Institute of Pharmacology
Intelliseq is a team of experienced scientists, geneticists, bioinformaticians and software engineers. We have already solved many problems for our clients globally.
Let us help you with yoursLearn more about our partners and the use cases from our collaboration.
Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms - bioinformatics analysis of RNA-seq
Task/Hypothesis: to explore the putative association between TLR4-mediated cytokine synthesis and subsequent symptoms of PSD.
Transcriptional alterations of prefrontal cortex astrocytes in a subpopulation of suicide completers - bioinformatics analysis of nuclei RNAseq
Task/Hypothesis: changes in the molecular profile of astrocytes may underlie metabolic reprogramming.
Identification of possibly pathogenic variants likely contributing to the risk of Gilles de la Tourette syndrome (GTS) and spectrum of tic disorders (TDs)
Problem/Task: the construction of an oligogenic risk model of GTS based on possibly pathogenic variants likely contributing to the risk of GTS and TDs.
Identification of the genetic variants contributing to the early-onset semantic dementia phenotype
Due to the overlapping clinical presentations and neuropathology, clinical diagnosis of dementia is frequently challenging and inconclusive. The use of next-generation sequencing methods revealed the complex genomic nature of disease phenotypes, shifting the pathogenicity model from monogenic to oligogenic inheritance.
Collaboration with ixLayer for Vitalleo
ixLayer is a US-based company that creates a complete solution for Health Testing by removing all the technical, security, and regulatory complexity involved in launching clients’ programs quickly and efficiently. This process provides a complete set of building blocks that enables leading health systems, clinical labs, biopharma, and consumer companies to offer precision health testing.
Cooperation with Adamed during MIT Enterprise Forum CEE acceleration program
In 2019, we got to the finals of the MITEF Central Eastern Europe acceleration program. MITEF CEE is a part of the global network of MIT Enterprise Forum, affiliated with the world’s best technology university – the Massachusetts Institute of Technology.
Transcriptomic research collaboration with BioMed X Institute
We have entered into cooperation with the independent research institute BioMed X that performs biomedical preclinical research projects in the fields of biomedicine, molecular biology, cell biology, and diagnostics.
Collaboration with Boehringer Ingelheim on the project dedicated to central nervous system diseases
The long-range goal of the study was to verify the usability of the Fkbp5 × ELA (early life adversity) mouse model for further investigation of the Fkbp5 gene variants influence on the resilience to stress. Single nucleotide polymorphisms (SNPs) in the human FKBP5 gene were previously shown to modulate the risk of stress-related disorders.
NGS pipeline development in cooperation with SCC Soft Computers
In 2019, we established cooperation with one of the largest LIS programming houses in the world SCC Soft Computers...
Partnership with Helix
In 2017, we have developed the MyTraits Sport mobile application – a translation of human genome into a personalized analysis of fitness-related traits. The app is available on the Helix marketplace for direct-to-consumer DNA-powered products.
Our most recent blog articles
Follow us and read our posts to learn more.
From genetic data to clinical insights. Automatically.